Gamm cautions against expecting too much, too soon. “It’s unreasonable to think that we are going to cure blindness in general, just like we’re not going to cure cancer with one magic bullet,” he says. “What we hope to do is make a meaningful change in a patient’s visual function, such that their activities of daily life are improved.”
Regenerative therapies for the eyes could help to save vision in people with glaucoma, macular degeneration and damaged corneas.
Talking about RejuvenateBio starts at 20:30. Mentions there are 300 known genes concerning human aging and 45 of those have been tested in mice with what sounds like success.
Wow! Where do I start. I woke up and seen Dr. George Church on Bloomberg news. They was discussing a new biotech startup company called Rejuvenate Bio. A life extension company that seeks to reverse aging in dogs. Then apply that knowledge to humans. I ask Dr. Church about what he thinks is the cause of aging. t. Dr. Church thinks its a genetic reason why we age. Dr. Church is a cofounder of a company called Colossal is a company that wants to create a hybrid between the east asian elephant and the woolly mammoth. The purpose of doing this is to fight climate change and prevent the extinction of the east asian elephant.
O,.o! Circa 2017
3D printers are useful devices for all kinds of reasons, but most have a critical weakness: they simply take a long time to actually make anything. That’s because additive manufacturing generally works by putting down an object one microscopic layer at a time. But a new holographic printing technique makes it possible to create the entire thing at once — in as little as a second or two.
Light-based 3D printing techniques generally use lasers to cause a layer of resin to harden in a pattern, but like extrusion printers, they have to do it layer by layer. If the laser shined all the way through the liquid resin, it would cause a big line of it to cure.
Continue reading “Holography-based 3D printing produces objects in seconds instead of hours” »
The structural integrity of the brain’s white matter as measured with an advanced MRI technique is lower in cognitively normal people who carry a genetic mutation associated with Alzheimer’s disease than it is in non-carriers, according to a study in Radiology. Researchers said the findings show the promise of widely available imaging techniques in helping to understand early structural changes in the brain before symptoms of dementia become apparent.
People who carry the autosomal dominant Alzheimer disease (ADAD) mutation have a higher risk of Alzheimer’s disease, a type of dementia that affects about one in nine people in the United States. The mutation is linked to a buildup of abnormal protein called amyloid-beta in the brain that affects both the gray matter and the signal-carrying white matter.
“It’s thought that the amyloid deposition in the gray matter could disrupt its function, and as a result the white matter won’t function correctly or could even atrophy,” said study lead author Jeffrey W. Prescott, M.D., Ph.D., neuroradiologist at the MetroHealth Medical Center in Cleveland.
Findings from study believed to be largest of its kind contradict smaller studies showing treatment’s promise.
Regular doses of the hormone oxytocin do not appear to overcome deficits in social functioning among children with autism spectrum disorder (ASD), suggests a study funded by the National Institutes of Health. The findings contradict earlier reports that indicated the hormone could alleviate the difficulties in social functioning characteristic of ASD. Oxytocin is associated with empathy and social bonding. The study was conducted by Linmarie Sikich, M.D., of Duke University, and colleagues. It appears in the New England Journal of Medicine.
Funding was provided by NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and National Center for Advancing Translational Sciences.
I had virtually no side-effects and was able to carry on as normal doing the things I love.
Implantable heart technology is being used in Manchester to assess when a patient is at high risk of dying, thanks to an NIHR ARC-GM and University of Manchester led research published today.
The pacemakers and defibrillators contain multiple sensors that allow continuous monitoring of a patient’s heart health, 24 hours a day. The study published in Europace and funded by the Medical Research Council is a collaboration between The University of Manchester, Manchester University NHS Foundation Trust (MFT), Health Innovation Manchester, the National Institute for Health Applied Research Collaboration Greater Manchester (ARC-GM) and Medtronic – who manufacture implantable devices.
The research team examined remotely monitored health related data from 439 patients at Manchester Royal Infirmary over two years. The study reported a three-fold increase in odds of mortality for patients who spent at least one day in high-risk status. There was also a 26% increase in the odds of mortality for patients who had 14 consecutive days or more in a high-risk status compared with those whose high-risk episodes were shorter. Higher percentages of time spent in a high-risk status, and less time in a low-risk status, were also associated with increased risk of death.
In 2,019 a survey from the Center for Digital Government (CDG), the National Association of Chief Information Officers and IBM found that just 13 percent of state governments reported using artificial intelligence in some non-core part of their operations. Three years later, the same survey yielded very different results.
At the NASCIO annual confference in Seattle this week, Joe Morris with CDG presented some of the study’s 2021 findings, and it was clear that the COVID-19 pandemic changed how state and local government are thinking about AI. This year, 60 percent of respondents reported AI is currently in use in their enterprise; 6.7 percent said the tech is widely used across the state, up from just 1 percent in 2019.
Continue reading “Artificial Intelligence Can Improve How People Use Tech” »
The is the world’s first biotech fine dust filter for urban spaces. Integrated moss modules bring the forest into the city and ensure that the air is verifiably and noticeably clean. We combine the natural filtering power of mosses with smart IoT technology. With an automated irrigation and ventilation system, the can clean and cool the surrounding air. Independent studies show that up to 82% of the fine dust in the air is filtered directly through the moss and the air is also cooled by up to 2.5 ° C.
